Company Description: Incircular's mission is to advance Biotech and Pharma applications by effective stabilization of proteins using INCYPRO, a cutting-edge chemical protein engineering technology that uses a powerful combination of computational and structural design, as well as selective chemical modification. The resulting INCYPRO-stabilized proteins are generated efficiently, have increased chemo- and thermo-stability, and show reduced aggregation, overall leading to improved activities. Incircular is leveraging its patented INCYPRO technology to generate a portfolio of stabilized proteins in collaboration with Pharma and Biotech partners. Having started as a spin-off company from the VU University Amsterdam, we have so far raised 3 million USD and are currently looking for a series A funding round by 2025.